Position in NVS
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$6,724,207
+$2,252,394 QoQ
Shares Held
44,021
+35.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TD Asset Management Inc holds $4,331,881,187 across 11 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,891,125 | $1,242,199,016 | |
| 2 | LLY |
ELI LILLY & Co
|
1,003,469 | $1,203,590,923 | |
| 3 | ABBV |
AbbVie Inc.
|
2,578,333 | $648,811,716 | |
| 4 | AZN |
Astrazeneca PLC
|
1,621,109 | $307,394,688 | |
| 5 | MRK |
Merck & Co., Inc.
|
2,334,726 | $300,012,291 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,971,583 | $249,089,796 | |
| 7 | AMGN |
Amgen Inc
|
420,259 | $152,184,189 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
2,007,448 | $115,669,153 |
All Filings in NVS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,724,207 | 44,021 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $4,471,813 | 32,435 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $3,182,275 | 24,815 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $2,504,907 | 20,700 | Shares | Defined | 2025-07-28 | |
| 2025-03-31 | $1,942,984 | 17,429 | Shares | Defined | 2025-05-07 | |
| 2024-12-31 | $1,562,312 | 16,055 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $1,852,627 | 16,107 | Shares | Defined | 2024-11-01 | |
| 2024-06-30 | $1,748,605 | 16,425 | Shares | Defined | 2024-08-02 | |
| 2024-03-31 | $5,025,703 | 51,956 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $5,563,043 | 55,096 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $1,352,802 | 13,281 | Shares | Defined | 2023-10-27 | |
| 2023-06-30 | $1,333,424 | 13,214 | Shares | Defined | 2023-08-09 | |
| 2023-03-31 | $1,266,840 | 13,770 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $1,314,442 | 14,489 | Shares | Defined | 2023-02-07 | |
| 2022-09-30 | $1,110,278 | 14,607 | Shares | Defined | 2022-11-07 | |
| 2022-06-30 | $1,109,794 | 13,129 | Shares | Defined | 2022-08-04 | |
| 2022-03-31 | $1,149,963 | 13,105 | Shares | Defined | 2022-05-10 | |
| 2021-12-31 | $1,170,785 | 13,385 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $1,100,022 | 13,451 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $4,190,561 | 45,929 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $3,885,920 | 45,460 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $4,022,529 | 42,598 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $4,884,804 | 56,173 | Shares | Defined | 2020-11-10 | |
| 2020-06-30 | $13,360,574 | 152,972 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $14,089,633 | 170,887 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||